Wissenschaftliche Arbeiten

Doç. Dr. İstemi Serin

130 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.

Zurück zum Profil
  1. A MALT LYMPHOMA PRESENTING WITH PRIMARY DIFFUSE RENAL INVOLVEMENT

    Eskisehir Medical Journal, Eskisehir City Hospital, 2023

    DOI 10.48176/esmj.2023.142 Frei zugänglicher VolltextQuelle: ORCID

  2. Charlson Comorbidity Index (CCI) in Diffuse Large B-cell Lymphoma: A New Approach in a Multicenter Study

    Indian Journal of Hematology and Blood Transfusion, 2023

    DOI 10.1007/s12288-022-01567-5 PMID 36186233 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  3. Association of Tumor Necrosis Factor-Alpha (TNF-α) and Suppressor of Cytokine Signaling-1 (SOCS-1) Gene Variants in Children with COVID-19

    Journal of Pediatric Infectious Diseases, 2023

    DOI 10.1055/s-0042-1759801 1 Zitation (OpenAlex) Quelle: ORCID

  4. PB2234: EFFECT OF HYDROXYUREA ON INFLAMMATORY MARKERS IN PATIENTS WITH BCR-ABL NEGATIVE MYELOPROLIFERATIVE DISEASES

    HemaSphere, 2023

    DOI 10.1097/01.hs9.0000975676.88150.33 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  5. The Obesity Controversy: Does It Impact Treatment Response in Diffuse Large B-Cell Lymphoma?

    International Journal of Hematology-Oncology and Stem Cell Research, 2023

    DOI 10.18502/ijhoscr.v17i2.12643 PMID 37637766 3 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  6. Clinical Outcomes of CNS Lymphoma Treated with Ibrutinib-Based Therapy: A Real-Life Multicenter Experience on Off-Label Use of Ibrutinib

    Kocaeli Üniversitesi - AVESİS, 2023

    DOI 10.4999/uhod.237297 1 Zitation (OpenAlex) Quelle: OpenAlex

  7. A COVID-19 mystery: multisystem inflammatory syndrome in adults (MIS-A) associated with splenic rupture.

    PubMed, 2023

    PMID 36853824 1 Zitation (OpenAlex) Quelle: OpenAlex

  8. Intravascular B‐cell lymphoma with generalized telangiectasias

    JDDG Journal der Deutschen Dermatologischen Gesellschaft, 2023

    DOI 10.1111/ddg.15148 PMID 37401140 1 Zitation (OpenAlex) Quelle: OpenAlex

  9. PB2075: HOW EFFECTIVE ARE LEPTIN GENE POLYMORPHISMS AND METHYLATION DURING THE COURSE OF MULTIPLE MYELOMA (MM)?

    HemaSphere, 2023

    DOI 10.1097/01.hs9.0000975096.44791.1e Frei zugänglicher VolltextQuelle: OpenAlex

  10. PB1897: GILTERITINIB IN TURKEY: EARLY ACCESS PROGRAM RESULTS

    HemaSphere, 2023

    DOI 10.1097/01.hs9.0000974412.42102.11 Frei zugänglicher VolltextQuelle: OpenAlex

  11. PB2334: CENTRAL NERVOUS SYSTEM (CNS) RELAPSE IN DIFFUSE LARGE B-CELL LYMPHOMA: CNS-SAMATYA RISK MODEL

    HemaSphere, 2023

    DOI 10.1097/01.hs9.0000976056.48193.1f Frei zugänglicher VolltextQuelle: OpenAlex

  12. PB2237: NON-THROMBOTIC INCREASED PORTAL VENOUS PRESSURE IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS: IS IT JUST A HYPOTHESIS?

    HemaSphere, 2023

    DOI 10.1097/01.hs9.0000975684.88590.d1 Frei zugänglicher VolltextQuelle: OpenAlex

  13. PB2321: THE EFFECT OF PRE-TREATMENT SERUM KINDLIN-3 ON HODGKIN AND NON-HODGKIN LYMPHOMAS: A SINGLE CENTER EXPERIENCE

    HemaSphere, 2023

    DOI 10.1097/01.hs9.0000976004.77004.33 Frei zugänglicher VolltextQuelle: OpenAlex

  14. PB2400: THE EFFECT OF BONE MARROW CD4/CD8+ RATIO ON RESPONSE TO TREATMENT AND SURVIVAL IN LYMPHOMAS

    HemaSphere, 2023

    DOI 10.1097/01.hs9.0000976312.04938.f6 Frei zugänglicher VolltextQuelle: OpenAlex

  15. PB1752: SAMATYA-PREDICTING SCORE IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): COMBINING CLINICAL FEATURES WITH FLOW CYTOMETRY

    HemaSphere, 2023

    DOI 10.1097/01.hs9.0000973868.81024.b4 Frei zugänglicher VolltextQuelle: OpenAlex

  16. PB2245: POLYCYTHEMIA VERA (PV) AND SECONDARY POLYCYTHEMIA (SP): ARE METABOLIC DIFFERENCES JUST THEORIES?

    HemaSphere, 2023

    DOI 10.1097/01.hs9.0000975716.97458.04 Frei zugänglicher VolltextQuelle: OpenAlex

  17. Intravaskuläres B‐Zell‐Lymphom mit generalisierten Teleangiektasien

    JDDG Journal der Deutschen Dermatologischen Gesellschaft, 2023

    DOI 10.1111/ddg.15148_g PMID 37700402 Frei zugänglicher VolltextQuelle: OpenAlex

  18. A Case of Diffuse Large B Cell Lymphoma with Unusual Extranodal Breast, Brain Involvement and Autoimmune Hemolytic Anemia: Clinical and Radiological Presentations

    Acta Oncologica Turcica, 2023

    DOI 10.5505/aot.2023.14890 Frei zugänglicher VolltextQuelle: OpenAlex

  19. Comparison of Efficacy and Safety of Generic Plerixafor Vs Original Plerixafor in the Mobilization of Myeloma Patients

    Blood, 2022

    DOI 10.1182/blood-2022-168558 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  20. Otolog Kök Hücre Transplantasyonunda Sitomegalovirüs (CMV) ve Hepatit B (HBV) Reaktivasyonu: Tek Merkez Deneyimi

    LLM Dergi, 2022

    DOI 10.5578/llm.20229802 Frei zugänglicher VolltextQuelle: OpenAlex

  21. Inherited transmission of the CSF3R T618I mutation: a familial report

    Annals of Hematology, 2022

    DOI 10.1007/s00277-022-05050-z PMID 36376598 Quelle: OpenAlex

  22. The suppressor of cytokine signaling-1 ( SOCS1 ) gene polymorphism and promoter methylation correlate with the course of COVID-19

    Pathogens and Global Health, 2022

    DOI 10.1080/20477724.2022.2151861 PMID 36448222 2 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  23. The Real-World Experience With Single Agent Ibrutinib in Relapsed/Refractory CLL

    Clinical Lymphoma, Myeloma and Leukemia, 2022

    DOI 10.1016/j.clml.2021.09.010 PMID 34629286 5 Zitationen (Europe PMC) Quelle: ORCID

  24. Efficacy of the lactate dehydrogenase (LDH)/lymphocyte ratio (LLR) to reduce the need for X-ray in pregnant patients with COVID-19

    Journal of Perinatal Medicine, 2022

    DOI 10.1515/jpm-2021-0341 PMID 35488442 2 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  25. To rechallenge or not to rechallenge, that is the question? An unsuccessful attempt of hypomethylating agent plus venetoclax in an elderly FLT3-positive relapsed acute myeloid leukemia patient after a yearlong period of remission

    Annals of Hematology, 2022

    DOI 10.1007/s00277-022-04938-0 PMID 35906348 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  26. Importance of mannose-binding lectin2 polymorphism (rs1800450) in infections in children

    Biomarkers, 2022

    DOI 10.1080/1354750x.2021.2003432 PMID 34747274 3 Zitationen (Europe PMC) Quelle: ORCID

  27. A Huge Mass in the Liver: Plasmacytoma

    The Turkish Journal of Hematology, 2022

    DOI 10.4274/tjh.galenos.2021.2021.0545 PMID 34753278 Frei zugänglicher VolltextQuelle: ORCID

  28. A new approach in acute myeloid leukemia (AML): Samatya-predicting score

    Leukemia Research Reports, 2022

    DOI 10.1016/j.lrr.2022.100293 PMID 35242525 Frei zugänglicher VolltextQuelle: ORCID

  29. Association of mannose-binding lectin 2 (MBL2) and suppressor of cytokine signaling-1 (SOCS1) gene variants in children with febrile neutropenia

    Journal of Infection and Chemotherapy, 2022

    DOI 10.1016/j.jiac.2022.01.012 PMID 35115241 Quelle: ORCID

  30. Enigma of COVID-19: is "multisystem inflammatory syndrome in adults" (MIS-A) predictable?

    BMC Infectious Diseases, 2022

    DOI 10.1186/s12879-022-07303-8 PMID 35346086 4 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  31. Epigenetic and genetic investigation of SOCS-1 gene in patients with multiple myeloma

    Blood Research, 2022

    DOI 10.5045/br.2022.2022097 PMID 36289192 3 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  32. First-line Usage of Daratumumab, Lenalidomide, Dexamethasone (DRd) Combination in a Case of Castleman Disease Variant of Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes Syndrome (CD-POEMS)

    HemaSphere, 2022

    DOI 10.1097/hs9.0000000000000728 PMID 35747589 5 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  33. Lateral flow assay (LFA) in the diagnosis of COVID-19-associated pulmonary aspergillosis (CAPA): a single-center experience

    BMC Infectious Diseases, 2022

    DOI 10.1186/s12879-022-07828-y PMID 36348480 5 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  34. Role of cytokines in multiple myeloma: IL-1RN and IL-4 VNTR polymorphisms

    Cytokine, 2022

    DOI 10.1016/j.cyto.2022.155851 PMID 35272075 4 Zitationen (Europe PMC) Quelle: ORCID

  35. A New Clock is Running for Multiple Myeloma: Circadian Clock Protein-Period 3 (PER-3) Polymorphism

    Balkan Journal of Medical Genetics, 2022

    DOI 10.2478/bjmg-2022-0026 PMID 37265974 7 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  36. Secondary Immunodeficiency Frequency in Patients with Chronic Lymphocytic Leukemia: The Relationship with Stage and Treatment

    International Journal of Hematology-Oncology and Stem Cell Research, 2022

    DOI 10.18502/ijhoscr.v16i1.8437 PMID 35975119 5 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  37. Could serum thrombocyte/lymphocyte (TLR), neutrophil/lymphocyte (NLR) and neutro-phil/albumin (NAR) ratios be indicators of hospitalization and mortality in COVID-19?

    Iranian Journal of Microbiology, 2022

    DOI 10.18502/ijm.v14i6.11266 PMID 36721444 4 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  38. Serum albumin and ferritin levels: a practical indicator of prognosis in acute myeloid leukemia over 50 years of age?

    PubMed Central, 2022

    PMID 35873101 5 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  39. Quality of Life Assessment with EORTC QLQ in Patients with Hodgkin Lymphoma: Multicenter Study

    Acta Oncologica Turcica, 2022

    DOI 10.5505/aot.2022.25991 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  40. Quality of Life Assessment with EORTC QLQ in Patients with Multiple Myeloma: Multicenter Study

    Forbes Journal of Medicine, 2022

    DOI 10.4274/forbes.galenos.2022.04274 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  41. PB1967: ROLE OF CYTOKINES IN MULTIPLE MYELOMA: IL-1RN AND IL-4 VNTR POLYMORPHISMS

    HemaSphere, 2022

    DOI 10.1097/01.hs9.0000850704.22267.04 Frei zugänglicher VolltextQuelle: OpenAlex

  42. Assesment of Patient'S Perspective on Treatment Free Remission in CML: A Turkish Multicenter Cohort

    Blood, 2022

    DOI 10.1182/blood-2022-165732 Quelle: OpenAlex

  43. A Real-life Turkish Experience of Venetoclax Treatment in High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia

    Clinical Lymphoma Myeloma & Leukemia, 2021

    DOI 10.1016/j.clml.2021.04.004 PMID 34059487 9 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  44. Investigation of MBL2 and NOS3 functional gene variants in suspected COVID-19 PCR (–) patients

    Pathogens and Global Health, 2021

    DOI 10.1080/20477724.2021.1984726 PMID 34570692 7 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  45. Is There a Link between Circadian Clock Protein PERIOD 3 (PER3) (rs57875989) Variant and the Severity of COVID-19 Infection?

    Current Medical Science, 2021

    DOI 10.1007/s11596-021-2442-y PMID 34542826 3 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  46. Relaps/Refrakter Lenfoma (Mantle Hücreli Lenfoma Hariç) Hastalarında Lenalidomid Bazlı Tedavi Sonuçları: Çok Merkezli Sonuçlar

    LLM Dergi, 2021

    DOI 10.5578/llm.20219602 Frei zugänglicher VolltextQuelle: ORCID

  47. The Use of Hypomethylating Agents in Hematologic Malignancies: Treatment Preferences and Results

    International Journal of Hematologic Oncology, 2021

    DOI 10.2217/ijh-2020-0019 PMID 35295753 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  48. Mucormycosis in Hematologic Malignancies: Clinical Follow-Up and Treatment Results

    Istanbul Medical Journal, 2021

    DOI 10.4274/imj.galenos.2021.65872 Frei zugänglicher VolltextQuelle: ORCID

  49. Subgroup Analysis in Multiple Myeloma Patients under Sixty Years: A Single-Center Study

    Istanbul Medical Journal, 2021

    DOI 10.4274/imj.galenos.2021.62593 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID

  50. Hemolytic anemia and plasma exchange

    Transfusion and Apheresis Science, 2021

    DOI 10.1016/j.transci.2021.103245 PMID 34412947 4 Zitationen (Europe PMC) Quelle: ORCID